{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:09:17Z","timestamp":1761743357888},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s12640-010-9204-0","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T18:16:12Z","timestamp":1277144172000},"page":"575-583","source":"Crossref","is-referenced-by-count":31,"title":["Exposure to Pyrithiamine Increases \u03b2-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain"],"prefix":"10.1007","volume":"19","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,22]]},"reference":[{"key":"9204_CR1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005072-198405000-00006","volume":"43","author":"H Aikawa","year":"1984","unstructured":"Aikawa H, Watanabe IS, Furuse T, Iwasaki Y, Satoyoshi E, Sumi T, Moroji T (1984) Low energy levels in thiamine-deficient encephalopathy. J Neuropath Exp Neurol 43:276\u2013287","journal-title":"J Neuropath Exp Neurol"},{"key":"9204_CR2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, Laferla FM (2005) Intraneuronal A-beta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45:675\u2013688","journal-title":"Neuron"},{"key":"9204_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00401-009-0539-7","volume":"117","author":"H Breyhan","year":"2009","unstructured":"Breyhan H, Wirths O, Duan K, Marcello A, Rettig J, Bayer TA (2009) APP\/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy. Acta Neuropathol 117:677\u2013685","journal-title":"Acta Neuropathol"},{"issue":"4","key":"9204_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00997071","volume":"5","author":"RF Butterworth","year":"1990","unstructured":"Butterworth RF, Besnard AM (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer\u2019s disease. Metab Brain Dis 5(4):179\u2013184","journal-title":"Metab Brain Dis"},{"key":"9204_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00996920","volume":"6","author":"RF Butterworth","year":"1991","unstructured":"Butterworth RF, Gaudreau C, Vincelette J, Bourgault AM, Lamothe F, Nutini AM (1991) Thiamine deficiency and Wernicke\u2019s encephalopathy in AIDS. Metab Brain Dis 6:207\u2013212","journal-title":"Metab Brain Dis"},{"key":"9204_CR6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"BW Doble","year":"2003","unstructured":"Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci 116:1175\u20131186","journal-title":"J Cell Sci"},{"key":"9204_CR7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.12.9.1511","volume":"12","author":"H Eldar-Finkelman","year":"2003","unstructured":"Eldar-Finkelman H, Ilouz R (2003) Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and type 2 diabetes treatment. Expert Opin Investig Drugs 12:1511\u20131519","journal-title":"Expert Opin Investig Drugs"},{"key":"9204_CR8","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2337\/diabetes.48.8.1662","volume":"48","author":"H Eldar-Finkelman","year":"1999","unstructured":"Eldar-Finkelman H, Schreyer SA, Shinohara MM, LeBoeuf RC, Krebs EG (1999) Increased glycogen synthase kinase-3 activity in diabetes and obesity-prone C57BL\/6J mice. Diabetes 48:1662\u20131666","journal-title":"Diabetes"},{"key":"9204_CR9","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1523\/JNEUROSCI.0604-06.2006","volume":"26","author":"T Engel","year":"2006","unstructured":"Engel T, Hernandez F, Avila J, Lucas JJ (2006) Full reversal of Alzheimer\u2019s disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J Neurosci 26:5083\u20135090","journal-title":"J Neurosci"},{"issue":"1","key":"9204_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3174\/ajnr.A0827","volume":"29","author":"GQ Fei","year":"2008","unstructured":"Fei GQ, Zhong C, Jin L, Wang J, Zhang Y, Zheng X, Zhang Y, Hong Z (2008) Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy. Am J Neuroradiol 29(1):164\u2013169","journal-title":"Am J Neuroradiol"},{"key":"9204_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-002-0587-8","volume":"104","author":"I Ferrer","year":"2002","unstructured":"Ferrer I, Barrachina M, Puig B (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated Tau deposits in Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 104:583\u2013591","journal-title":"Acta Neuropathol"},{"key":"9204_CR12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/14728222.10.3.429","volume":"10","author":"S Frame","year":"2006","unstructured":"Frame S, Zheleva D (2006) Targeting glycogen synthase kinase-3 in insulin signalling. Expert Opin Ther Targets 10:429\u2013444","journal-title":"Expert Opin Ther Targets"},{"key":"9204_CR13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","volume":"7","author":"S Frame","year":"2001","unstructured":"Frame S, Cohen P, Biondi RM (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:1321\u20131327","journal-title":"Mol Cell"},{"issue":"5","key":"9204_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/REVNEURO.2004.15.5.353","volume":"15","author":"DC German","year":"2004","unstructured":"German DC, Eisch AJ (2004) Mouse models of Alzheimer\u2019s disease: insight into treatment. Rev Neurosci 15(5):353\u2013369","journal-title":"Rev Neurosci"},{"key":"9204_CR15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/ars.2007.1766","volume":"9","author":"GE Gibson","year":"2007","unstructured":"Gibson GE, Blass JP (2007) Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxid Redox Signal 9:1605\u20131619","journal-title":"Antioxid Redox Signal"},{"key":"9204_CR16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF00965667","volume":"9","author":"GE Gibson","year":"1984","unstructured":"Gibson GE, Ksiezak-Reding H, Sheu KFR, Mykytyn V, Blass JP (1984) Correlation of enzymatic, metabolic and behavioral deficits in thiamine deficiency and its reversal. Neurochem Res 9:803\u2013814","journal-title":"Neurochem Res"},{"key":"9204_CR17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","volume":"45","author":"GE Gibson","year":"1988","unstructured":"Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease. Arch Neurol 45:836\u2013840","journal-title":"Arch Neurol"},{"key":"9204_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neubiorev.2006.07.007","volume":"31","author":"L Gim\u00e9nez-Llort","year":"2007","unstructured":"Gim\u00e9nez-Llort L, Bl\u00e1zquez G, Ca\u00f1ete T, Johansson B, Oddo S, Tobe\u00f1a A, LaFerla FM, Fern\u00e1ndez-Teruel A (2007) Modeling behavioral and neuronal symptoms of Alzheimer\u2019s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125\u2013147","journal-title":"Neurosci Biobehav Rev"},{"key":"9204_CR19","first-page":"407","volume":"8","author":"M Glaso","year":"2004","unstructured":"Glaso M, Nordabo G, Diep L, Bohmer T (2004) Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging 8:407\u2013413","journal-title":"J Nutr Health Aging"},{"key":"9204_CR20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archneur.1995.00540350075019","volume":"52","author":"M Gold","year":"1995","unstructured":"Gold M, Chen MF, Johnson K (1995) Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer\u2019s type. Arch Neurol 52:1081\u20131086","journal-title":"Arch Neurol"},{"issue":"1","key":"9204_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1020678912330","volume":"13","author":"M Gold","year":"1998","unstructured":"Gold M, Hauser RA, Chen MF (1998) Plasm thiamine deficiency associated with Alzheimer\u2019s disease but not Parkinson\u2019s disease. Metab Brain Dis 13(1):43\u201345","journal-title":"Metab Brain Dis"},{"issue":"2","key":"9204_CR22","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1259\/bjr\/97295129","volume":"80","author":"K Herholz","year":"2007","unstructured":"Herholz K, Carter SF, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80(2):S160\u2013S167","journal-title":"Br J Radiol"},{"key":"9204_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02080933","volume":"11","author":"M H\u00e9roux","year":"1996","unstructured":"H\u00e9roux M, Raghavendra Rao VL, Lavoie J, Richardson JS, Butterworth RF (1996) Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer\u2019s disease. Metab Brain Dis 11:81\u201388","journal-title":"Metab Brain Dis"},{"key":"9204_CR24","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci USA 96:3228\u20133233","journal-title":"Proc Natl Acad Sci USA"},{"key":"9204_CR25","first-page":"179","volume":"121","author":"K Imahori","year":"1997","unstructured":"Imahori K, Uchida T (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer\u2019s disease. J Biochem (Tokyo) 121:179\u2013188","journal-title":"J Biochem (Tokyo)"},{"issue":"10","key":"9204_CR26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.12.013","volume":"30","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE (2009) Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer\u2019s mouse model. Neurobiol Aging 30(10):1587\u20131600","journal-title":"Neurobiol Aging"},{"key":"9204_CR27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11270-7","volume":"186","author":"AM Kennedy","year":"1995","unstructured":"Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P et al (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer\u2019s disease. Neurosci Lett 186:17\u201320","journal-title":"Neurosci Lett"},{"key":"9204_CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-3002(58)90192-6","volume":"29","author":"JC Koedam","year":"1958","unstructured":"Koedam JC (1958) The mode of action of pyrithiamine as an inductor of thiamine deficiency. Biochim Biophys Acta 29:333\u2013344","journal-title":"Biochim Biophys Acta"},{"key":"9204_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-3002(56)90407-3","volume":"19","author":"JC Koedam","year":"1956","unstructured":"Koedam JC, Steyn-Parve EP, van Rheenen DL (1956) Thiamine deficiency after feeding pyrithiamine. Biochim Biophys Acta 19:181\u2013182","journal-title":"Biochim Biophys Acta"},{"key":"9204_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","volume":"33","author":"K Leroy","year":"2007","unstructured":"Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3beta in Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33:43\u201355","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9204_CR31","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1074\/jbc.M510951200","volume":"281","author":"JY Liu","year":"2006","unstructured":"Liu JY, Timm DE, Hurley TD (2006) Pyrithiamine as a substrate for thiamine pyrophosphokinase. J Biol Chem 281:6601\u20136607","journal-title":"J Biol Chem"},{"key":"9204_CR32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.50.5.937","volume":"50","author":"PA Lochhead","year":"2001","unstructured":"Lochhead PA, Coghlan M, Rice SQ, Sutherland C (2001) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50:937\u2013946","journal-title":"Diabetes"},{"key":"9204_CR33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","volume":"45","author":"A Martinez","year":"2002","unstructured":"Martinez A, Alonso M, Castro A, Perez C, Moreno F (2002) First non-ATP competitive glycogen kinase 3 (GSK3) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer\u2019s disease. J Med Chem 45:1292\u20131299","journal-title":"J Med Chem"},{"key":"9204_CR34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.410390507","volume":"39","author":"F Mastrogiacoma","year":"1996","unstructured":"Mastrogiacoma F, Bettendorff L, Grisar T, Kish SJ (1996) Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer\u2019s disease. Ann Neurol 39:585\u2013591","journal-title":"Ann Neurol"},{"key":"9204_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","volume":"23","author":"O Masuo","year":"2006","unstructured":"Masuo O, Lei C, Wilbur T, Holly O, Martin C, William LK, Robert V, John FD (2006) Temporal memory deficits in Alzheimer\u2019s mouse models: rescue by genetic deletion of BACE1. Eur J Neurosci 23:251\u2013260","journal-title":"Eur J Neurosci"},{"key":"9204_CR36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1530-0277.2008.00671.x","volume":"32","author":"S Matsushita","year":"2008","unstructured":"Matsushita S, Miyakawa T, Maesato H, Matsui T, Yokoyama A, Arai H, Higuchi S, Kashima H (2008) Elevated cerebrospinal fluid tau protein levels in Wernicke\u2019s encephalopathy. Alcohol Clin Exp Res 32:1091\u20131095","journal-title":"Alcohol Clin Exp Res"},{"key":"9204_CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm020319p","volume":"46","author":"Y Mettey","year":"2003","unstructured":"Mettey Y, Gompel M, Thomas V, Garnier M, Leost M, Ceballos-Picot I, Noble M, Endocott J, Vierfond JM, Meijer L (2003) Aloisines, a new family of CDK\/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem 46:222\u2013236","journal-title":"J Med Chem"},{"key":"9204_CR38","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","volume":"274","author":"D Moechars","year":"1999","unstructured":"Moechars D, Dewachter I, Lorent K, Revers\u00e9 D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483\u20136492","journal-title":"J Biol Chem"},{"key":"9204_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195","journal-title":"Ann N Y Acad Sci"},{"key":"9204_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/diabetes.49.2.263","volume":"49","author":"SE Nikoulina","year":"2000","unstructured":"Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR (2000) Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49:263\u2013271","journal-title":"Diabetes"},{"key":"9204_CR41","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129\u201310140","journal-title":"J Neurosci"},{"key":"9204_CR42","doi-asserted-by":"crossref","unstructured":"Pan XL, Gong N, Zhao J, Yu Z, Gu FH, Chen J, Sun XJ, Zhao L, Yu MJ, Xu ZR, Dong WX, Qin Y, Fei GQ, Zhong C, Xu TL (2010) Powerful beneficial effects of benfotiamine on cognitive impairment and A\u03b2 deposition in APP\/PS1 transgenic mice. Brain. doi: 10.1093\/brain\/awq069","DOI":"10.1093\/brain\/awq069"},{"key":"9204_CR43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1212\/WNL.34.11.1477","volume":"34","author":"WD Parker Jr","year":"1984","unstructured":"Parker WD Jr, Haas R, Stumpf DA, Parks J, Eguren LA, Jackson C (1984) Brain mitochondrial metabolism in experimental thiamine deficiency. Neurology 34:1477\u20131481","journal-title":"Neurology"},{"issue":"6938","key":"9204_CR44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VMY, Klein PS (2003) GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides. Nature 423(6938):435\u2013439","journal-title":"Nature"},{"key":"9204_CR45","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1523\/JNEUROSCI.4321-06.2007","volume":"27","author":"E Rockenstein","year":"2007","unstructured":"Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer\u2019s disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci 27:1981\u20131991","journal-title":"J Neurosci"},{"issue":"9","key":"9204_CR46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.55.9.1242","volume":"55","author":"T Shimomura","year":"1998","unstructured":"Shimomura T, Mori E, Hirono N, Imamura T, Yamashita H (1998) Development of Wernicke-Korsakoff syndrome after long intervals following gastrectomy. Arch Neurol 55(9):1242\u20131245","journal-title":"Arch Neurol"},{"key":"9204_CR47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis. Neuron 60:534\u2013542","journal-title":"Neuron"},{"key":"9204_CR48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","volume":"13","author":"S Sorbi","year":"1983","unstructured":"Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13:72\u201378","journal-title":"Ann Neurol"},{"key":"9204_CR49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2006-9S335","volume":"9","author":"A Takashima","year":"2006","unstructured":"Takashima A (2006) GSK-3 is essential in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis 9:309\u2013317","journal-title":"J Alzheimers Dis"},{"key":"9204_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ageing\/29.2.111","volume":"29","author":"TJ Wilkinson","year":"2000","unstructured":"Wilkinson TJ, Hanger C, George PM, Sainsbury R (2000) Is thiamine deficiency in elderly people related to age or co-morbidity? Age Ageing 29:111\u2013116","journal-title":"Age Ageing"},{"key":"9204_CR51","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","volume":"9","author":"JR Woodgett","year":"1990","unstructured":"Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3\/factor A. EMBO J 9:2431\u20132438","journal-title":"EMBO J"},{"issue":"100","key":"9204_CR52","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/stke.2001.100.re12","volume":"2001","author":"JR Woodgett","year":"2001","unstructured":"Woodgett JR (2001) Judging a protein by more than its name: GSK-3. Sci STKE 2001(100):re12","journal-title":"Sci STKE"},{"key":"9204_CR53","doi-asserted-by":"crossref","unstructured":"Zhang Q, Yang G, Li W, Fan Z, Sun A, Luo J, Ke ZJ (2009) Thiamine deficiency increases beta-secretase activity and accumulation of beta-amyloid peptides. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2009.01.005","DOI":"10.1016\/j.neurobiolaging.2009.01.005"},{"issue":"2","key":"9204_CR54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2009.06341.x","volume":"111","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Pan X, Zhao J, Wang Y, Peng Y, Zhong C (2009) Decreased transketolase activity contributes to impaired hippocampal neurogenesis induced by thiamine deficiency. J Neurochem 111(2):537\u2013546","journal-title":"J Neurochem"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-010-9204-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9204-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:42:29Z","timestamp":1685641349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-010-9204-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,22]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["9204"],"URL":"https:\/\/doi.org\/10.1007\/s12640-010-9204-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,22]]}}}